Miika M. Mehine

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Journal: Cancer cell
Published: April 19, 2026

Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

Journal: Journal of the National Cancer Institute
Published: April 13, 2026

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.

Journal: Acta neuropathologica
Published: June 20, 2025

Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma.

Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma.

Journal: European urology
Published: June 12, 2025

Transcriptome profiling of uterine leiomyosarcomas identifies a leiomyoma-like expression pattern that indicates better survival.

Transcriptome profiling of uterine leiomyosarcomas identifies a leiomyoma-like expression pattern that indicates better survival.

Journal: BJC reports
Published: April 03, 2025

Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.

Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.

Journal: NPJ precision oncology
Published: April 02, 2025

Genomic landscape of endometrial polyps.

Genomic landscape of endometrial polyps.

Journal: Genome medicine
Published: December 17, 2024

Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.

Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: September 10, 2024

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Journal: Cancer cell
Published: April 26, 2024

Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation.

Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation.

Journal: eLife
Published: April 25, 2024

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Journal: Nature
Published: April 03, 2024

Chromothripsis-Mediated Small Cell Lung Carcinoma.

Chromothripsis-Mediated Small Cell Lung Carcinoma.

Journal: Cancer discovery
Published: March 01, 2024
Showing 1-12 of 40

Last Updated: 09/26/2026